Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Primary retroiridal iris-claw IOL implantation instead of capsular bag implantation during phacoemulsification in cases of lentodonesis due to zonular weakness

Poster Details

First Author: J. Kuchenbecker GERMANY

Co Author(s):                        

Abstract Details

Purpose:

In-the-bag IOL dislocation after phacoemulsification is a common problem in cases of zonula weakness. In most cases it needs further surgical intervention.

Setting:

Department of Ophthalmolgy, Helios Hospital Berlin Buch, Berlin, Germany

Methods:

In a case series of 6 eyes (1 OD, 5 OS) of 6 patients ( 1 femal and 5 male, mean age 79.0 ± 7.2 years) with lentodonesis (6 pseudoexfoliation (PEX), 1 trauma) due to zonula weakness during phacoemulsification a primary retroiridal iris-claw IOL (Verisyse®, range from 15 D to 22D IOL power) implantation was performed.

Results:

Postoperative mean follow-up was 12.2 ± 11.7 months. CDVA (LogMAR) improved in all patients (0.97 ± 0.57 preoperatively vs 0.35 ± 0.21 postoperatively, P=0.03). Mean preoperative spherical equivalent (SE) was -0.33 ± 1.99 D and mean postoperative spherical equivalent (SE) was 0.33 ± 1.03 D (p>0.05). Mean IOP was preoperative 17.7 ± 4.1 mmHg and postoperative 13.0 ± 4.5 mmHg (p>0.05). In one case anterior vitrectomy due to partial zonulolysis was necessary. No other intraoperative or postoperative complications occured in any cases.

Conclusions:

Instead of capsular bag implantation a primary retroiridal iris-claw IOL implantation during phacoemulsification was performed in cases with lentodonesis due to zonula weakness. It is a safe and simple procedure. Probably these procedure can prevent in-the-bag IOL dislocation and cystic macular edema.

Financial Disclosure:

NONE

Back to Poster listing